LMR Partners’s EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share EQHA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-50,000
Closed -$494K 1546
2022
Q3
$494K Hold
50,000
0.01% 878
2022
Q2
$492K Hold
50,000
0.01% 923
2022
Q1
$490K Hold
50,000
0.01% 986
2021
Q4
$486K Hold
50,000
0.01% 922
2021
Q3
$489K Hold
50,000
0.01% 780
2021
Q2
$36K Buy
+50,000
New +$28.3K ﹤0.01% 1027

Other funds holding EQHA.WS

LMR Partners's EQHA.WS Position: Q4 2022 in Review

LMR Partners sold out of EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share (EQHA.WS) in Q4 2022, closing a stake of 50,000 shares — an estimated $494K sold.

LMR Partners first reported a position in EQHA.WS in Q2 2021 and held it in 6 quarters. The position peaked at $494K in Q3 2022. 1 fund tracked by Wall St. Rank holds EQHA.WS as of Q4 2022.

  • LMR Partners reported no remaining EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position as of Q4 2022 after selling out during the quarter.
  • LMR Partners sold 50,000 EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share shares in Q4 2022, an estimated $494K.
  • LMR Partners first reported a position in EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share in Q2 2021 and held it in 6 quarters.
  • LMR Partners's EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position peaked at $494K in Q3 2022.
  • 1 fund tracked by Wall St. Rank held EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share as of Q4 2022.

Based on LMR Partners's 13F filing for Q4 2022, filed 14 Feb 2023.